Dimensional Fund Advisors’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.95M Buy
180,050
+58,496
+48% +$3.23M ﹤0.01% 2277
2025
Q1
$5.88M Sell
121,554
-104,046
-46% -$5.03M ﹤0.01% 2453
2024
Q4
$8.71M Buy
225,600
+11
+0% +$425 ﹤0.01% 2360
2024
Q3
$10.2M Sell
225,589
-390,583
-63% -$17.6M ﹤0.01% 2303
2024
Q2
$21.3M Sell
616,172
-175,172
-22% -$6.07M 0.01% 1929
2024
Q1
$22.9M Sell
791,344
-25,193
-3% -$729K 0.01% 1914
2023
Q4
$18.7M Sell
816,537
-124,737
-13% -$2.86M 0.01% 2019
2023
Q3
$15.7M Sell
941,274
-97,831
-9% -$1.63M 0.01% 2052
2023
Q2
$28.7M Sell
1,039,105
-223,154
-18% -$6.16M 0.01% 1728
2023
Q1
$29M Buy
1,262,259
+185,033
+17% +$4.26M 0.01% 1706
2022
Q4
$11.8K Buy
1,077,226
+256,788
+31% +$2.8K ﹤0.01% 2124
2022
Q3
$6.92M Sell
820,438
-32,337
-4% -$273K ﹤0.01% 2308
2022
Q2
$6.75M Sell
852,775
-10,117
-1% -$80K ﹤0.01% 2352
2022
Q1
$20.4M Sell
862,892
-11,759
-1% -$278K 0.01% 1953
2021
Q4
$29.9M Sell
874,651
-1,081
-0.1% -$37K 0.01% 1765
2021
Q3
$15.5M Buy
875,732
+84,716
+11% +$1.5M 0.01% 2121
2021
Q2
$35.5M Buy
791,016
+134,915
+21% +$6.05M 0.01% 1710
2021
Q1
$17M Buy
656,101
+6,561
+1% +$170K 0.01% 2089
2020
Q4
$13.1M Sell
649,540
-35,716
-5% -$720K ﹤0.01% 2174
2020
Q3
$13.4M Sell
685,256
-1,641
-0.2% -$32.1K 0.01% 2057
2020
Q2
$12.1M Buy
686,897
+13,249
+2% +$234K 0.01% 2130
2020
Q1
$4.76M Buy
673,648
+2,897
+0.4% +$20.5K ﹤0.01% 2427
2019
Q4
$4.73M Sell
670,751
-60,554
-8% -$427K ﹤0.01% 2629
2019
Q3
$8.78M Sell
731,305
-12,753
-2% -$153K ﹤0.01% 2396
2019
Q2
$9.01M Buy
744,058
+80,281
+12% +$972K ﹤0.01% 2429
2019
Q1
$8.34M Buy
663,777
+173,510
+35% +$2.18M ﹤0.01% 2471
2018
Q4
$3.3M Buy
490,267
+122,250
+33% +$823K ﹤0.01% 2720
2018
Q3
$3.79M Buy
368,017
+140,200
+62% +$1.44M ﹤0.01% 2766
2018
Q2
$1.53M Buy
+227,817
New +$1.53M ﹤0.01% 2942